Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues.

Pisaneschi F, Lin YH, Leonard PG, Satani N, Yan VC, Hammoudi N, Raghavan S, Link TM, K Georgiou D, Czako B, Muller FL.

Molecules. 2019 Jul 9;24(13). pii: E2510. doi: 10.3390/molecules24132510.

2.

Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation.

Sun Y, Bandi M, Lofton T, Smith M, Bristow CA, Carugo A, Rogers N, Leonard P, Chang Q, Mullinax R, Han J, Shi X, Seth S, Meyers BA, Miller M, Miao L, Ma X, Feng N, Giuliani V, Geck Do M, Czako B, Palmer WS, Mseeh F, Asara JM, Jiang Y, Morlacchi P, Zhao S, Peoples M, Tieu TN, Warmoes MO, Lorenzi PL, Muller FL, DePinho RA, Draetta GF, Toniatti C, Jones P, Heffernan TP, Marszalek JR.

Cell Rep. 2019 Jan 8;26(2):469-482.e5. doi: 10.1016/j.celrep.2018.12.043.

3.

An inhibitor of oxidative phosphorylation exploits cancer vulnerability.

Molina JR, Sun Y, Protopopova M, Gera S, Bandi M, Bristow C, McAfoos T, Morlacchi P, Ackroyd J, Agip AA, Al-Atrash G, Asara J, Bardenhagen J, Carrillo CC, Carroll C, Chang E, Ciurea S, Cross JB, Czako B, Deem A, Daver N, de Groot JF, Dong JW, Feng N, Gao G, Gay J, Do MG, Greer J, Giuliani V, Han J, Han L, Henry VK, Hirst J, Huang S, Jiang Y, Kang Z, Khor T, Konoplev S, Lin YH, Liu G, Lodi A, Lofton T, Ma H, Mahendra M, Matre P, Mullinax R, Peoples M, Petrocchi A, Rodriguez-Canale J, Serreli R, Shi T, Smith M, Tabe Y, Theroff J, Tiziani S, Xu Q, Zhang Q, Muller F, DePinho RA, Toniatti C, Draetta GF, Heffernan TP, Konopleva M, Jones P, Di Francesco ME, Marszalek JR.

Nat Med. 2018 Jul;24(7):1036-1046. doi: 10.1038/s41591-018-0052-4. Epub 2018 Jun 11.

PMID:
29892070
4.

SF2312 is a natural phosphonate inhibitor of enolase.

Leonard PG, Satani N, Maxwell D, Lin YH, Hammoudi N, Peng Z, Pisaneschi F, Link TM, Lee GR 4th, Sun D, Prasad BAB, Di Francesco ME, Czako B, Asara JM, Wang YA, Bornmann W, DePinho RA, Muller FL.

Nat Chem Biol. 2016 Dec;12(12):1053-1058. doi: 10.1038/nchembio.2195. Epub 2016 Oct 10.

5.

Synthesis and opioid activity of novel 6-substituted-6-demethoxy-ethenomorphinans.

Czakó B, Marton J, Berényi S, Gach K, Fichna J, Storr M, Tóth G, Sipos A, Janecka A.

Bioorg Med Chem. 2010 May 15;18(10):3535-42. doi: 10.1016/j.bmc.2010.03.068. Epub 2010 Mar 29.

PMID:
20413312
6.

Discovery of potent and practical antiangiogenic agents inspired by cortistatin A.

Czakó B, Kürti L, Mammoto A, Ingber DE, Corey EJ.

J Am Chem Soc. 2009 Jul 1;131(25):9014-9. doi: 10.1021/ja902601e.

PMID:
19469509
7.

A short, scalable synthesis of the carbocyclic core of the anti-angiogenic cortistatins from (+)-estrone by B-ring expansion.

Kürti L, Czakó B, Corey EJ.

Org Lett. 2008 Nov 20;10(22):5247-50. doi: 10.1021/ol802328n. Epub 2008 Oct 30.

PMID:
18959422
8.

Construction of bicyclic ring systems via a transannular SmI2-mediated ketone-olefin cyclization strategy.

Molander GA, Czakó B, Rheam M.

J Org Chem. 2007 Mar 2;72(5):1755-64. Epub 2007 Feb 2. Erratum in: J Org Chem. 2007 Nov 23;72(24):9406.

9.

A general route toward the synthesis of the cladiellin skeleton utilizing a SmI2-mediated cyclization.

Molander GA, Czakó B, St Jean DJ Jr.

J Org Chem. 2006 Feb 3;71(3):1172-80.

Supplemental Content

Loading ...
Support Center